N/A N=268

Follow-Up Extension to the Family Study of Binge Eating Disorder

Binge Eating Disorder

Bottom Line

View on ClinicalTrials.gov: NCT00777634 ↗

Enrolled (actual)

268

Serious AEs

—

Results posted

May 2012

Primary outcome: Primary: Incidence of Diagnosis of Dyslipidemia — 34; 18 participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: No intervention. (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Mclean Hospital
Primary completion: Nov 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Incidence of Diagnosis of Dyslipidemia	34; 18	—
PRIMARY Incidence of Diagnosis of Hypertension	25; 18	—
PRIMARY Incidence of Diagnosis of Type 2 Diabetes	13; 10	—
PRIMARY Incidence of Diagnosis of Any Metabolic Syndrome Component	53; 37	—
PRIMARY Incidence of Diagnosis of Two or More Metabolic Syndrome Components	18; 8	—
PRIMARY Incidence of Diagnosis of Three or More Metabolic Syndrome Components	1; 1	—

Summary

This study involves a 2.5 and 5 year follow-up interview for individuals who participated in the initial family study of binge eating disorder. The study includes individuals with and without eating disorder as well as their first degree relatives. As part of the study, participants will be interviewed about their current psychiatric and medical symptoms, their blood pressure will be measured, and laboratory specimens will be obtained.

Eligibility Criteria

Inclusion Criteria

Individuals with or without binge eating disorder and their family members who participated in the initial family study of binge eating disorder and agree to be followed up at 2.5 and 5 years.

Exclusion Criteria

Unwilling or unable to participate in the follow-up study.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00777634). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.